Precigen to participate in a virtual fireside chat at cantor's "the future of oncology" virtual symposium

Germantown, md. , march 28, 2023 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will participate in a virtual fireside chat on april 4, 2023 from 10:45 am to 11:15 am et at cantor's "the future of oncology" virtual symposium.
PGEN Ratings Summary
PGEN Quant Ranking